And yet again, when presented with the case for
embryonic stem cell research primarily on the grounds of curing disease, the respondents expressed support.
Tarne demonstrates that funding has moved from grants directed
primarily towards
embryonic stem cell research toward
primarily ethical
stem cells research — which has been the only
stem cell research to date to result in positive treatments for illnesses.